E. Ohman J or Asset Management AB Has $5.06 Million Stock Position in Penumbra, Inc. (NYSE:PEN)

E. Ohman J or Asset Management AB grew its stake in Penumbra, Inc. (NYSE:PEN) by 10.4% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 21,312 shares of the company’s stock after buying an additional 2,000 shares during the quarter. E. Ohman J or Asset Management AB owned 0.06% of Penumbra worth $5,061,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Northwestern Mutual Wealth Management Co. increased its holdings in Penumbra by 1,845.0% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 389 shares of the company’s stock worth $70,000 after purchasing an additional 369 shares in the last quarter. Handelsbanken Fonder AB boosted its position in shares of Penumbra by 17.7% during the third quarter. Handelsbanken Fonder AB now owns 10,658 shares of the company’s stock worth $2,071,000 after buying an additional 1,600 shares during the period. GAMMA Investing LLC grew its holdings in shares of Penumbra by 111.1% during the third quarter. GAMMA Investing LLC now owns 171 shares of the company’s stock worth $33,000 after buying an additional 90 shares in the last quarter. Diversified Trust Co raised its position in Penumbra by 22.8% in the 3rd quarter. Diversified Trust Co now owns 9,971 shares of the company’s stock valued at $1,937,000 after buying an additional 1,852 shares during the last quarter. Finally, Park Place Capital Corp lifted its stake in Penumbra by 1,473.9% in the 3rd quarter. Park Place Capital Corp now owns 362 shares of the company’s stock valued at $70,000 after acquiring an additional 339 shares in the last quarter. Institutional investors own 88.88% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on PEN. Citigroup raised their price target on shares of Penumbra from $220.00 to $245.00 and gave the stock a “neutral” rating in a research note on Wednesday, December 11th. Robert W. Baird lifted their price target on shares of Penumbra from $244.00 to $248.00 and gave the company an “outperform” rating in a research note on Thursday, October 31st. UBS Group assumed coverage on shares of Penumbra in a research note on Tuesday, January 21st. They set a “buy” rating and a $305.00 price objective for the company. Canaccord Genuity Group lifted their target price on Penumbra from $260.00 to $323.00 and gave the company a “buy” rating in a research report on Monday, December 9th. Finally, Oppenheimer began coverage on Penumbra in a report on Tuesday, December 17th. They set an “outperform” rating and a $275.00 target price on the stock. Four research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $261.36.

Penumbra Price Performance

NYSE:PEN opened at $265.00 on Tuesday. The firm’s fifty day moving average price is $250.90 and its two-hundred day moving average price is $218.90. The company has a debt-to-equity ratio of 0.02, a current ratio of 5.82 and a quick ratio of 3.25. The company has a market cap of $10.17 billion, a P/E ratio of 308.14, a P/E/G ratio of 1.96 and a beta of 0.53. Penumbra, Inc. has a one year low of $148.00 and a one year high of $277.89.

Insider Activity at Penumbra

In other news, CAO Lambert Shiu sold 654 shares of the firm’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $243.01, for a total transaction of $158,928.54. Following the transaction, the chief accounting officer now directly owns 20,028 shares of the company’s stock, valued at approximately $4,867,004.28. This trade represents a 3.16 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Johanna Roberts sold 600 shares of Penumbra stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $239.74, for a total transaction of $143,844.00. Following the completion of the sale, the executive vice president now owns 64,044 shares of the company’s stock, valued at approximately $15,353,908.56. The trade was a 0.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 33,819 shares of company stock worth $8,129,483. Insiders own 5.00% of the company’s stock.

About Penumbra

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.